SonALAsense Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $46M

  • Investors
  • 8

SonALAsense General Information

Description

Developer of a sonodynamic therapy platform designed for the noninvasive treatment of cancer. The company utilizes a drug-device combination that pairs a tumor-targeting drug with focused ultrasound to deliver the drug to cancer cells, enabling oncology patients to access targeted therapy that avoids debilitating surgery and induces programmed cell death.

Contact Information

Website
www.sonalasense.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 409 14th Street
  • Oakland, CA 94612
  • United States
+1 (510)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Therapeutic Devices
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 409 14th Street
  • Oakland, CA 94612
  • United States
+1 (510)

SonALAsense Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SonALAsense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 14-Feb-2025 $46M Completed Clinical Trials - Phase 2
6. Early Stage VC 02-Nov-2023 Completed Clinical Trials - Phase 2
5. Early Stage VC 01-May-2023 Completed Clinical Trials - Phase 2
4. Grant 01-Jun-2022 Completed Clinical Trials - Phase 2
3. Grant 01-May-2022 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 06-Jan-2022 $20.1M $25M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 01-Feb-2021 $4.93M $4.93M Completed Clinical Trials - Phase 1
To view SonALAsense’s complete valuation and funding history, request access »

SonALAsense Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view SonALAsense’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

SonALAsense Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

SonALAsense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021385582-A1 Metabolic targeting of low grade tumors Inactive 30-Nov-2020
AU-2021385582-A9 Metabolic targeting of low grade tumors Inactive 30-Nov-2020
CA-3200226-A1 Metabolic targeting of low grade tumors Pending 30-Nov-2020
EP-4252001-A1 Metabolic targeting of low grade tumors Inactive 30-Nov-2020
EP-4252001-A4 Metabolic targeting of low grade tumors Inactive 30-Nov-2020 A61K49/0021
To view SonALAsense’s complete patent history, request access »

SonALAsense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SonALAsense Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARPA-H Government
TK & Partners Venture Capital Minority
National Cancer Institute I-Corps Accelerator/Incubator
National Institutes of Health Government
Ben And Catherine Ivy Foundation Impact Investing Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

SonALAsense FAQs

  • When was SonALAsense founded?

    SonALAsense was founded in 2019.

  • Where is SonALAsense headquartered?

    SonALAsense is headquartered in Oakland, CA.

  • What is the size of SonALAsense?

    SonALAsense has 10 total employees.

  • What industry is SonALAsense in?

    SonALAsense’s primary industry is Drug Delivery.

  • Is SonALAsense a private or public company?

    SonALAsense is a Private company.

  • What is SonALAsense’s current revenue?

    The current revenue for SonALAsense is .

  • How much funding has SonALAsense raised over time?

    SonALAsense has raised $34.8M.

  • Who are SonALAsense’s investors?

    ARPA-H, TK & Partners, National Cancer Institute I-Corps, National Institutes of Health, and Ben And Catherine Ivy Foundation are 5 of 8 investors who have invested in SonALAsense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process